1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- A single dose of intravenous combretastatin A4-phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers
- Clinical use of organic near-infrared fluorescent contrast agents in image-guided oncologic procedures and its potential in veterinary oncology
- Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs
- A dose-escalation study of combretastatin A4-phosphate in healthy dogs
- 2017
- Negative pressure wound therapy : the past and the future
- Combretastatin A4-phosphate and its potential in veterinary oncology : a review
- 2016
- De hond als kankermodel in de zoektocht naar nieuwe therapeutische alternatieven
- 2015
- Treatment of necrotizing fasciitis using negative pressure wound therapy in a puppy
- 2013
- Necrotizing fasciitis in a dog